It was observed that the use of the CCL2-neutralizing antibody significantly reversed the CM-BMA-PA-induced deteriorated biological behavior and elevated the expressions of tumor-associated genes in PC-3 cells (Fig. 4A, C-D). Here, CCL2 is linked to neoplasm.